A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
National Institutes of Health Clinical Center (CC)
Varian, a Siemens Healthineers Company
Novartis
AstraZeneca
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Kivu Bioscience Inc.
AstraZeneca
BeOne Medicines
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
Pfizer
Ohio State University Comprehensive Cancer Center
Travera Inc
Iambic Therapeutics, Inc
Nammi Therapeutics Inc
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Health Network, Toronto
Jazz Pharmaceuticals
Fred Hutchinson Cancer Center
Novartis
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Amgen
Alliance for Clinical Trials in Oncology
Genmab
Fate Therapeutics
Conjupro Biotherapeutics, Inc.
Wake Forest University Health Sciences
DualityBio Inc.
National Institutes of Health Clinical Center (CC)
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
Conjupro Biotherapeutics, Inc.
NRG Oncology
NRG Oncology
Mayo Clinic
Astellas Pharma Inc
Institut Cancerologie de l'Ouest
University of Vic - Central University of Catalonia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Avera McKennan Hospital & University Health Center
City of Hope Medical Center
GlaxoSmithKline